Old Web
English
Sign In
Acemap
>
authorDetail
>
Dendra VonMerveldt
Dendra VonMerveldt
University of Texas Southwestern Medical Center
Medicine
Ipilimumab
Nivolumab
Pathology
Renal cell carcinoma
4
Papers
43
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Combination of dual immune checkpoint inhibition (ICI) with stereotactic radiation (SBRT) in metastatic renal cell carcinoma (mRCC) (RADVAX RCC).
2020
Journal of Clinical Oncology
Hans J. Hammers
Dendra VonMerveldt
Chul Ahn
Rosa Nadal
Charles G. Drake
Michael R. Folkert
Aaron M. Laine
Kevin D. Courtney
James Brugarolas
Danny Y. Song
Raquibul Hannan
Michael A. Carducci
Show All
Source
Cite
Save
Citations (23)
Clinical activity of ipilimumab plus nivolumab (Ipi/Nivo) in patients (pts) with metastatic non-clear cell renal cell carcinoma (nccRCC).
2019
Journal of Clinical Oncology
Ruby Gupta
Moshe Chaim Ornstein
Anita Gul
Kimberly D Allman
Jessica Ball
Laura S. Wood
Jorge A. Garcia
Dendra VonMerveldt
Hans J. Hammers
Brian I. Rini
Show All
Source
Cite
Save
Citations (9)
Clinical activity of ipilimumab plus nivolumab in patients with metastatic non-clear cell renal cell carcinoma
2019
Clinical Genitourinary Cancer
Ruby Gupta
Moshe Chaim Ornstein
Hong Li
Kimberly D Allman
Laura S. Wood
Timothy D. Gilligan
Jorge A. Garcia
Dendra VonMerveldt
Hans J. Hammers
Brian I. Rini
Show All
Source
Cite
Save
Citations (11)
Neoadjuvant therapy preceding cytoreductive nephrectomy to develop individualized first-line therapy with everolimus for advanced renal cell carcinoma (RCC).
2017
Journal of Clinical Oncology
Guru Sonpavde
Gilad E. Amiel
Vitaly Margulis
Richard E. Link
Seth P. Lerner
Ganesh V. Raj
Wesley A. Mayer
Ganesh S. Palapattu
Yair Lotan
Arthur I. Sagalowsky
Linda C Higgins
Sebrina A Tello
Andrea Pavia-Jimenez
Dendra VonMerveldt
James Brugarolas
Show All
Source
Cite
Save
Citations (0)
1